SCHEMBL2633398

SCHEMBL2633398

CCN1CCC2(CC1)Cc1ccccc1O2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.54
DRD2 P14416 3/20 0.51
HTR2A P28223 2/20 0.51
ADRA1D P25100 4/20 0.45
ADRA1A P35348 4/20 0.45
ADRA1B P35368 4/20 0.45
HTR2C P28335 1/20 0.43
KCNH2 Q12809 1/20 0.43
CCR1 P32246 2/20 0.43
CCR5 P51681 1/20 0.42
TRPM8 Q7Z2W7 1/20 0.39
CYP2D6 P10635 2/20 0.38
TSHR P16473 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP1A2 P05177 1/20 0.38
PKM P14618 1/20 0.38
NFKB1 P19838 1/20 0.38
THPO P40225 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11288065 0.98 SIGMAR1 (0.52) SIGMAR1DRD2HTR2AADRA1DADRA1A
SCHEMBL2633399 0.91 SIGMAR1 (0.51) SIGMAR1DRD2HTR2AADRA1DADRA1A
SCHEMBL2633460 0.84 SIGMAR1 (0.42) SIGMAR1DRD2HTR2AADRA1DADRA1A
SCHEMBL2743253 0.83 KMT2A (0.49) SIGMAR1DRD2HTR2AADRA1DADRA1A
Hydrochloric Acid SCHEMBL11263972 0.82 KMT2A (0.48) SIGMAR1DRD2HTR2AADRA1DADRA1A
SCHEMBL864155 0.82 SIGMAR1 (0.79) SIGMAR1DRD2HTR2AHTR2CCYP2D6
SCHEMBL1789621 0.82 DRD2 (0.56) SIGMAR1DRD2HTR2AADRA1DADRA1A
SCHEMBL19852295 0.81 SIGMAR1 (0.50) SIGMAR1DRD2HTR2AADRA1DADRA1A
Hydrochloric Acid SCHEMBL11193368 0.81 SIGMAR1 (0.77) SIGMAR1DRD2HTR2AHTR2CCYP2D6
Hydrochloric Acid SCHEMBL11543251 0.81 SIGMAR1 (0.51) SIGMAR1DRD2HTR2AADRA1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11033547-B2 Carboxamide-pyrimidine derivatives as SHP2 antagonists MERCK PATENT GMBH (DE) 2021-06-15 US disclosed
US-20200281926-A1 CARBOXAMIDE-PYRIMIDINE DERIVATIVES AS SHP2 ANTAGONISTS MERCK PATENT GMBH (DE) 2020-09-10 US disclosed
US-8269000-B2 Substituted pyrimidine and triazine compounds GRUENENTHAL GMBH (DE) 2012-09-18 US disclosed
US-8158628-B2 Sulfonylated 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine compounds and their use as pharmaceuticals GRUENENTHAL GMBH (DE) 2012-04-17 US disclosed
US-20100234340-A1 Substituted Spiroamide Compounds GRUENENTHAL GMBH (DE) 2010-09-16 US disclosed
US-20100234387-A1 Sulfonylated Tetrahydroazolopyrazines and their Use as Pharmaceuticals GRUENETHAL GMBH (DE) 2010-09-16 US disclosed
US-20100222324-A1 Substituted Indole Compounds GRUENENTHAL GMBH (DE) 2010-09-02 US disclosed
US-20100173889-A1 Substituted Pyrimidine and Triazine Compounds GRUENENTHAL GMBH (DE) 2010-07-08 US disclosed
US-20100152158-A1 Substituted Disulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152158-A1 Substituted Disulfonamide Compounds BDKRB1, BDKRB2, BRS3 SIGMAR1 288/4885DRD2 147/4885HTR2A 774/4885
US-20100222324-A1 Substituted Indole Compounds BDKRB1, BDKRB2, EDNRB SIGMAR1 222/4885DRD2 36/4885HTR2A 85/4885
US-20100234387-A1 Sulfonylated Tetrahydroazolopyrazines and their Use as Pharmaceuticals BDKRB1, BDKRB2, KCNB1 SIGMAR1 166/4885DRD2 834/4885HTR2A 239/4885
US-11033547-B2 Carboxamide-pyrimidine derivatives as SHP2 antagonists PTPN5, PTPN2, PTPN1 SIGMAR1 4194/4885DRD2 4845/4885HTR2A 3399/4885
US-20100173889-A1 Substituted Pyrimidine and Triazine Compounds ADORA2B, CCNB1, TYMS SIGMAR1 1220/4885DRD2 672/4885HTR2A 256/4885
US-20100234340-A1 Substituted Spiroamide Compounds BDKRB1, BDKRB2, AVPR1B SIGMAR1 398/4885DRD2 1063/4885HTR2A 625/4885
US-20200281926-A1 CARBOXAMIDE-PYRIMIDINE DERIVATIVES AS SHP2 ANTAGONISTS PTPN5, PTPN2, PTPN1 SIGMAR1 4194/4885DRD2 4845/4885HTR2A 3399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.